Jump to Navigation
Login
Home
Login to Your Account
Username:
*
Password:
*
Lost password?
Register now
Help!
advanced search
about us
advertising
BioWorld’s Partner in Focus
archives
editorial guidelines
faqs
publications
BioWorld Today
BioWorld International
BioWorld Insight
BioWorld Snapshots
BioWorld Market Reports
BioScan Online
store
Reports
Conferences
site map
explore »
about
conferences
reports
staff
store
start a risk-free subscription
U.S NEWS
Top Headlines
BW Today
BW Insight
BW International
Pfizer Phase III Failure Hints at ADC Shortcomings
GSK's Academic Competition Aims to Accelerate Innovation
AB Science's Masitinib Enters Phase III Trial for Alzheimer's
Post-Ampligen FDA Workshop Leads to CFS Guidance Pledge
Novo Snags Xellia for $700M; Continues Investment Strategy
Embryonic Stem Cells: Individual Medicine - But With 2 Individuals
Money Raised By Biotech In 2013 vs. 2012
Mirna Puts First MicroRNA Mimic into the Clinic
Gilead Data Suggest Targeted Cancer Drugs Coming of Age
Money Raised By Biotech: Jan. 1 - May 16, 2013
Elan Looks East with 2 Deals as Royalty Revises Hostile Bid
GSK's Academic Competition Aims to Accelerate Innovation
Peptide Study Raises Hopes for New Sepsis Treatment
Novo Snags Xellia for $700M; Continues Investment Strategy
MS Ventures Expands, Moves Early Firms Along Dual Track
Current BioWorld Today Issue »
Current BioWorld Insight Issue »
Current BioWorld International Issue »
US Patent Disclosures
Appointments and Advancements
Clinical Roundup
Other News to Note
Pharma: Other News to Note
Pharma: Clinical Roundup
Cast Your Vote
What is biopharma’s biggest need on the regulatory front?:
Implementation of the JOBS Act provisions
Social media guidance
More predictability in FDA’s drug reviews
More biosimilar guidance
Tax reforms to enhance and make permanent the R&D credit
Faster approval path for anti-infectives
More funding for Alzheimer’s
Other
BIOWORLD ON TWITTER
